Diverse mechanisms of Sp1-Dependent transcriptional regulation potentially involved in the adaptive response of cancer cells to oxygen-deficient conditions

Cancers

Volumn 8, Issue 1, 2015, Pages

  Koizume, Shiro ^a   Miyagi, Yohei ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Cancer; Hypoxia; Sp1; Transcriptional regulation

Indexed keywords

BLOOD CLOTTING FACTOR 7; CARBONATE DEHYDRATASE IX; CD147 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ENDOSIALIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INTERLEUKIN 8; ISOCITRATE DEHYDROGENASE 2; KRUPPEL LIKE FACTOR 6; LEPTIN; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; PRION PROTEIN; PROTEIN MSH2; PROTEIN MSH6; SIRTUIN 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR SP1; UROKINASE RECEPTOR; VASCULOTROPIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADAM17 GENE; ATP7A GENE; BINDING SITE; CA9 GENE; CANCER CELL; CCL2 GENE; CD147 GENE; CD248 GENE; CDKN1A GENE; CXCL8 GENE; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENO3 GENE; ENZYME ACTIVATION; ERCC2 GENE; F3 GENE; FVII GENE; GAPDH GENE; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE INTERACTION; HIF1A GENE; HUMAN; HYPOXIA; ICAM1 GENE; IDH2 GENE; JUN GENE; KLF6 GENE; LEP GENE; MDR1 GENE; MMP14 GENE; MSH2 GENE; MSH6 GENE; NDRG1 GENE; NONHUMAN; PAI1 GENE; PKM GENE; PLAUR GENE; PRNP GENE; PROMOTER REGION; PROTEIN BINDING; RADIOSENSITIVITY; REVIEW; RNA INTERFERENCE; RORA GENE; SIGNAL TRANSDUCTION; SIRT1 GENE; SP1 GENE; TNXB GENE; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; UNFOLDED PROTEIN RESPONSE; VEGF GENE; XPC GENE; ZBTB7A GENE;

EID: 84951959021     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers8010002     Document Type: Review

References (75)

1. 2 availability on human cancer. Nat. Rev. Cancer 2008, 8, 967-975. [CrossRef] [PubMed]
2. Keith, B.; Simon, MC. Hypoxia inducible factors, Stem cells, and Cancer. Cell 2007, 129, 465-472. [CrossRef] [PubMed]
3. Keith, B.; Johnson, R.S.; Simon, M.C. HIF1α and HIF2α: Sibling rivalry in hypoxic tumor growth and progression. Nat. Rev. Cancer 2012, 12, 9-22. [CrossRef] [PubMed]
4. Dengler, V.L.; Galbraith, M.; Espinosa, J.M. Transcriptional regulation by hypoxia inducible factors. Crit. Rev. Biochem. Mol. Biol. 2014, 49, 1-15. [CrossRef] [PubMed]
5. Dewhirst, M.W.; Cao, Y.; Moeller, B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 2008, 8, 425-437. [CrossRef] [PubMed]
6. Casazza, A.; di Conza, G.; Wenes, M.; Finisguerra, V.; Deschomaeker, S.; Mazzone, M. Tumor stroma: A complexity dictated by the hypoxic tumor microenvironment. Oncogene 2014, 33, 1743-1754. [CrossRef] [PubMed]
7. Wouters, B.G.; Koritzinsky, M. Hypoxia signaling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8, 851-864. [CrossRef] [PubMed]
8. Wierstra, I. Sp1: Emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 2008, 372, 1-13. [CrossRef] [PubMed]
9. Beishline, K.; Azizkhan-Clifford, J. Sp1 and the "hallmarks of cancer". FEBS J. 2015, 282, 224-258. [CrossRef] [PubMed]
10. Comerford, K.M.; Wallace, T.J.; Karhausen, J.; Louis, N.A.; Montalto, M.C.; Colgan, S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002, 62, 3387-3394. [PubMed]
11. Miki, N.; Ikuta, M.; Matsui, T. hypoxia-induced activation of the retinoic acid receptor-related orphan receptor a4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J. Biol. Chem. 2004, 279, 15025-15031. [CrossRef] [PubMed]
12. Ke, X.; Fei, F.; Chen, Y.; Xu, L.; Zhang, Z.; Huang, Q.; Zhang, H.; Yang, H.; Chen, Z.; Xing, J. Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epitherial solid tumors. Carcinogenesis 2012, 33, 1598-1607. [CrossRef] [PubMed]
13. Kaluz, S.; Kaluzova, M.; Stanbridge, E.J. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res. 2003, 63, 917-922. [PubMed]
14. G250/MN by HIF-1α in clear renal cell carcinoma. Oncogene 2004, 23, 5624-5631. [CrossRef] [PubMed]
15. Higashimura, Y.; Nakajima, Y.; Yamaji, R.; Harada, N.; Shibasaki, F.; Nakano, Y.; Inui, H. Up-regulation of glyceraldehydes-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells. Arch. Biochem. Biophys. 2011, 509, 1-8. [CrossRef] [PubMed]
16. Bartella, V.; Cascio, S.; Fiorio, E.; Auriemma, A.; Russo, A.; Surmacz, E. Insulin-dependent leptin expression in breast cancer cells. Cancer Res. 2008, 68, 4919-4927. [CrossRef] [PubMed]
17. Xie, L.; Collins, J.F. Transcription factors Sp1 and HIF2α mediate induction of the copper-transporting ATPase (Atp7a) gene in intestinal epitherial cells during hypoxia. J. Biol. Chem. 2013, 288, 23943-23952. [CrossRef] [PubMed]
18. Sato, M.; Tanaka, T.; Maemura, K.; Ucjyama, T.; Sato, H.; Maeno, T.; Suga, T.; Iso, T.; Ohyama, Y.; Arai, M.; et al. The PAI-1 gene as a direct target of endotherial PAS domain protein-1 in adenocarcinoma A549 cells. Am. J. Respir. Cell Mol. Biol. 2004, 31, 209-215. [CrossRef] [PubMed]
19. Petrella, B.L.; Lohi, J.; Brinckerhoff, C.E. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma. Oncogene 2005, 24, 1043-1052. [CrossRef] [PubMed]
20. Yeh, S.H.; Yang, W.B.; Gean, P.W.; Hsu, C.Y.; Tseng, J.T.; Su, T.P.; Chang, W.C.; Hung, J.J. Translational and transcriptional control of Sp1 against ischemia through a hydrogen peroxide-activated internal ribosomal entry site pathway. Nucleic Acids Res. 2011, 39, 5412-5423. [CrossRef] [PubMed]
21. Jeong, J.-K.; Park, S.-Y. Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha (HIF-1α) leads to PRNP expression and neuroprotection from toxic prion peptide. Biochem. Biophys. Res. Commun. 2012, 429, 93-98. [CrossRef] [PubMed]
22. Szalad, A.; Katakowski, M.; Zheng, X.; Jiang, F.; Chopp, M. Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia. J. Exp. Clin. Cancer Res. 2009, 28, 129. [CrossRef] [PubMed]
23. Ohradanova, A.; Gradin, K.; Barathova, M.; Zatovicova, M.; Holotnakova, T.; Kopacek, J.; Parkkila, S.; Poellinger, L.; Pastorekova, S.; Pastorek, J. Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2. Br. J. Cancer 2008, 99, 1348-1356. [CrossRef] [PubMed]
24. Rouleau, C.; Gianolio, D.A.; Smale, R.; Roth, S.D.; Krumbholz, R.; Harper, J.; Munroe, K.J.; Green, T.L.; Horten, B.C.; Schmid, S.M.; et al. Anti-endosialin antibody-drug conjugate: Potential in sarcoma and other malignancies. Mol. Cancer Ther. 2015, 14, OF1-OF9. [CrossRef] [PubMed]
25. Woo, S.K.; Kwon, M.S.; Geng, Z.; Chen, Z.; Ivanov, A.; Bhatta, S.; Gerzanich, V.; Simard, J.M. Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8. J. Cereb. Blood Flow Metab. 2012, 32, 525-536. [CrossRef] [PubMed]
26. Florczyk, U.; Czauderna, S.; Stachurska, A.; Tertil, M.; Nowak, W.; Kozakowska, M.; Poellinger, L.; Jozkowicz, A.; Loboda, A.; Dulak, J. Opposite effects of HIF-1α and HIF-2α on the regulation of IL-8 in endothelial cells. Free Radic. Biol. Med. 2011, 51, 1882-1892. [CrossRef] [PubMed]
27. Discher, D.J.; Bishopric, N.H.; Wu, X.; Peterson, C.A.; Webster, K.A. Hypoxia regulates β-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J. Biol. Chem. 1998, 273, 26087-26093. [CrossRef] [PubMed]
28. Pal, S.; Datta, K.; Mukhopadhyay, D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res. 2001, 61, 6952-6957. [PubMed]
29. Choi, S.B.; Park, J.B.; Song, T.-J.; Choi, S.Y. Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line. Int. J. Mol. Med. 2011, 28, 449-454. [PubMed]
30. Pore, N.; Gupta, A.K.; Cerniglia, G.J.; Jiang, Z.; Bernhard, E.J.; Evans, S.M.; Koch, C.J.; Hahn, S.M.; Maity, A. Nelfinavir down-regulates hypoxia-inducible factor 1α and VEGF expression and increases tumor oxygenation: Implications for radiotherapy. Cancer Res. 2006, 66, 9252-9259. [CrossRef] [PubMed]
31. Kim, S.Y.; Park, J.-W. Modulation of hypoxia-inducible factor-1α expression by mitochondrial NADP+-dependent isocitrate dehydrogenase. Biochimie 2010, 92, 1908-1913. [CrossRef] [PubMed]
32. Chakraborty, G.; Rangaswami, H.; Jain, S.; Kundu, G.C. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. J. Biol. Chem. 2006, 281, 11322-11331. [CrossRef] [PubMed]
33. Kunz, M.; Bloss, G.; Gillitzer, R.; Gross, G.; Goebeller, M.; Rapp, U.R.; Ludwig, S. Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: Involvement of nuclear factor-kB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways. Biochem. J. 2002, 366, 299-306. [CrossRef] [PubMed]
34. Trisciuoglio, D.; Iervolino, A.; Candiloro, A.; Fibbi, G.; Fanciulli, M.; Zangemeister-Wittke, U.; Zupi, G.; Del Bufalo, D. Bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation. J. Biol. Chem. 2004, 279, 6737-6745. [CrossRef] [PubMed]
35. Kato, A.; Endo, T.; Abiko, S.; Ariga, H.; Matsumoto, K. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. Exp. Cell Res. 2008, 314, 2661-2673. [CrossRef] [PubMed]
36. Sun, L.; Li, H.; Chen, J.; Iwasaki, Y.; Kubota, T.; Matsuoka, M.; Shen, A.; Chen, Q.; Xu, Y. PIASy mediates hypoxia-induced SIRT1 transcriptionalrepression and epithelial-to-mesenchymal transition in ovarian cancer cells. J. Cell Sci. 2013, 126, 3939-3947. [CrossRef] [PubMed]
37. Sun, L.; Li, H.; Chen, J.; Dehennaut, V.; Zhao, Y.; Yang, Y.; Iwasaki, Y.; Kahn-Perles, B.; Leprince, D.; Chen, Q.; et al. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. J. Natl. Cancer Inst. 2013, 105, 887-898. [CrossRef] [PubMed]
38. Culver, C.; Melvin, A.; Mudie, S.; Rocha, S. HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs. Cell Cycle 2011, 10, 1249-1260. [CrossRef] [PubMed]
39. Su, W.; Jackson, S.; Tijan, R.; Echols, H. DNA looping between sites for transcriptional activation: Self-association of DNA-bound Sp1. Genes Dev. 1991, 5, 820-826. [CrossRef] [PubMed]
40. Miura, A.; Kambe, Y.; Inoue, K.; Tatsukawa, H.; Kurihara, T.; Griffin, M.; Kojima, S.; Miyata, A. Pituitary adenylate cyclase-activating polypeptide type 1receptor (PAC1) gene is suppressed by transglutaminase 2 activation. J. Biol. Chem. 2013, 288, 32720-32730. [CrossRef] [PubMed]
41. Koizume, S.; Jin, M.-S.; Miyagi, E.; Hirahara, F.; Nakamura, Y.; Piao, J.-H.; Asai, A.; Yoshida, A.; Tsuchiya, E.; Ruf, W.; et al. Activation of cancer cell migration and invasion by ectopic expression of coagulation factor VII. Cancer Res. 2006, 66, 9453-9460. [CrossRef] [PubMed]
42. Rezvani, H.R.; Mahfouf,W.; Ali, N.; Chemin, C.; Ged, C.; Kim, A.L.; de Verneuil, H.; Taieb, A.; Bickers, D.R.; Mazurier, F. Hypoxia-inducible factor-1a regulates the expression of nucleotide excision repair proteins in keratinocytes. Nucleic Acids Res. 2010, 38, 797-809. [CrossRef] [PubMed]
43. Zhang, P.; Tchou-Wong, K.M.; Costa, M. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res. 2007, 67, 9125-9133. [CrossRef] [PubMed]
44. Koizume, S.; Miyagi, Y. Suppressing the TF-fVII pathway at the gene expression level: A strategy to inhibit aberrant signaling cascades associated with cancer cells. Cancer Cell Microenviron. 2015, 2, e734.
45. Yan, S.-F.; Lu, J.; Zou, Y.S.; Soh-Won, J.; Cohen, D.M.; Buttrick, P.M.; Cooper, D.R.; Steinberg, S.F.; Mackman, N.; Pinsky, D.J.; et al. Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 1999, 274, 15030-15040. [CrossRef] [PubMed]
46. Koshiji, M.; To, K.K.-W.; Hammer, S.; Kumamoto, K.; Harris, A.L.; Modrich, P.; Huang, L.E. HIF-1α induces genetic instability by transcriptionally downregulating MutSα expression. Mol. Cell 2005, 17, 793-803. [CrossRef] [PubMed]
47. To, K.K.-W.; Sedelnikova, O.A.; Samons, M.; Bonner, W.M.; Huang, L.E. The phosphorylation status of PAS-B distinguishes HIF-1α from HIF-2α in NBS1 repression. EMBO J. 2006, 25, 4784-4794. [CrossRef] [PubMed]
48. Gordan, J.D.; Bertout, J.A.; Hu, C-J.; Diehl, J.A.; Simon, M.C. HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity. Cancer Cell 2007, 11, 335-347. [CrossRef] [PubMed]
49. Koizume, S.; Ito, S.; Miyagi, E.; Hirahara, F.; Nakamura, Y.; Sakuma, Y.; Osaka, H.; Takano, Y.; Ruf, W.; Miyagi, Y. HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells. Nucleic Acids Res. 2012, 40, 5389-5401. [CrossRef] [PubMed]
50. Koizume, S.; Ito, S.; Nakamura, Y.; Yoshihara, M.; Furuya, M.; Yamada, R.; Miyagi, E.; Hirahara, F.; Takano, Y.; Miyagi, Y. Lipid starvation and hypoxia synergistically activates ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Mol. Cancer 2015, 14, 77. [CrossRef] [PubMed]
51. Wang, X.; Cao, P.; Li, Z.;Wu, D.;Wang, X.; Liang, G. EPAS-1 mediates SP-1-dependent FBI-1 expression and regulates tumor cell survival and proliferation. Int. J. Mol. Sci. 2014, 15, 15689-15699. [CrossRef] [PubMed]
52. Koizume, S.; Miyagi, Y. Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia. Genom. Data 2015, 5, 129-131. [CrossRef] [PubMed]
53. Koshikawa, N.; Hayashi, J.; Nakagawara, A.; Takenaga, K. Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1α gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J. Biol. Chem. 2009, 48, 33185-33194. [CrossRef] [PubMed]
54. Archer, M.C. Roles of Sp1 transcription factors in the regulation of cancer cell metabolism. Genes Cancer 2011, 2, 712-719. [CrossRef] [PubMed]
55. Zawacka-Pankau, J.; Grinkevich, V.V.; Hunten, S.; Nikulenkov, F.; Gluch, A.; Li, H.; Enge, M.; Kel, A.; Selivanova, G. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53. J. Biol. Chem. 2011, 48, 41600-41615. [CrossRef] [PubMed]
56. Vlaminck, B.; Toffoli, S.; Ghislain, B.; Demazy, C.; Raes, M.; Michiels, C. Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions. FEBS J. 2007, 274, 5533-5542. [CrossRef] [PubMed]
57. Semenza, G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148, 399-408. [CrossRef] [PubMed]
58. Lafleur, V.N.; Richard, S.; Richard, D.E. Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1. Mol. Biol. Cell 2014, 25, 925-935. [CrossRef] [PubMed]
59. Masuda, K.; Ono, M.; Okamoto, M.; Morikawa, W.; Otsubo, M.; Migita, T.; Tsuneyoshi, M.; Okuda, H.; Shuin, T.; Naito, S.; et al. Downregulation of CAP4 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells. Int. J. Cancer 2003, 105, 803-810. [CrossRef] [PubMed]
60. Ghandhi, S.A.; Ponnaiya, B.; Panigrahi, S.K.; Hopkins, K.M.; Cui, Q.; Hei, T.K.; Amundson, S.A.; Lieberman, H.B. RAD9 deficiency enhances radiation induced bystander DNA damage and transcriptomal response. Radiat. Oncol. 2014, 9, 206. [CrossRef] [PubMed]
61. Ranhotra, H.S. The interplay between retinoic acid receptor-related orphan receptors and human diseases. J. Recept. Signal Transduct. Res. 2012, 32, 181-189. [CrossRef] [PubMed]
62. DiFeo, A.; Narla, G.; Martignetti, J.A. Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment. Mt. Sinai J. Med. 2009, 76, 557-566. [CrossRef] [PubMed]
63. Simmen, R.C.M.; Pabona, J.M.P.; Velarde, M.C.; Simmons, C.; Rahal, O.; Simmen, F.A. The emerging role of Krüppel-like factors in endocrine-responsive cancers of female reproductive tissues. J. Endocrinol. 2010, 204, 223-231. [CrossRef] [PubMed]
64. Hess, J.; Angel, P.; Schorpp-Kistner, M. AP-1 subunits: Quarrel and harmony among siblings. J. Cell Sci. 2004, 117, 5965-5973. [CrossRef] [PubMed]
65. Shaurian, E. AP-1-the Jun proteins: Oncogene or tumor suppressors in disguise? Cell Signal. 2010, 22, 894-899.
66. Zhang, J.-Y.; Zhang, F.; Hong, C.-Q.; Giuliano, A.E.; Cui, X.-J.; Zhou, G.-J.; Zhang, G.-J.; Cui, Y.K. Critical protein GAPDH and its regulatory mechanisms in cancer cells. Cancer Biol. Med. 2015, 12, 10-22. [PubMed]
67. Dowling, P.; Hughes, D.J.; Larkin, A.M.; Meiller, J.; Henry, M.; Meleady, P.; Lynch, V.; Pardini, B.; Naccarati, A.; Levy, M.; et al. Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer. Clin. Chim. Acta 2015, 441, 133-141. [CrossRef] [PubMed]
68. Koppenol, W.H.; Bounds, P.L.; Dang, C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11, 325-337. [CrossRef] [PubMed]
69. Reitman, Z.J.; Yan, H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: Alterations at crossroads of cellular metabolism. J. Natl. Cancer Inst. 2010, 102, 932-941. [CrossRef] [PubMed]
70. Chiquet-Ehrismann, R.; Tucker, R.P. Tenascins and the importance of adhesion modulation. Cold Spring Harb. Perspect. Biol. 2011, 3, a004960. [CrossRef] [PubMed]
71. Brellier, F.; Chiquet-Ehrismann, R. How do tenacins influence the birth and life of a malignant cell? J. Cell. Mol. Med. 2012, 16, 32-40. [CrossRef] [PubMed]
72. Koizume, S.; Ito, S.; Yoshioka, Y.; Kanayama, T.; Nakamura, Y.; Yoshihara, M.; Yamada, R.; Ochiya, T.; Ruf,W.; Miyagi, E.; et al. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors. Thromb. Haemost. 2015. [CrossRef] [PubMed]
73. Liu, C.; Lin, Q.; Yun, Z. Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity. Radiat. Res. 2015, 183, 487-496. [CrossRef] [PubMed]
74. Wilson,W.R.; Hay, M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11, 393-410. [CrossRef] [PubMed]
75. Semenza, G.L. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J. Clin. Investig. 2013, 123, 3664-3671. [CrossRef] [PubMed]